Future research on HIFs aims to further elucidate their roles in various physiological and pathological processes. The development of selective inhibitors or activators of HIF pathways holds therapeutic potential for conditions such as cancer, ischemic diseases, and metabolic disorders. Advances in single-cell RNA sequencing and other high-throughput techniques will also enhance our understanding of HIF regulation and function at the cellular level.
